Chondroadherin (CHAD) Peptide
Quick Overview for Chondroadherin (CHAD) Peptide (ABIN974887)
Target
Origin
Source
Application
-
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-CHAD antibody (Catalog #: ARP51926_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- CHAD (Chondroadherin (CHAD))
-
Background
-
Chondroadherin is a cartilage matrix protein thought to mediate adhesion of isolated chondrocytes. CHAD contains 11 leucine-rich repeats flanked by cysteine-rich regions. The chondroadherin messenger RNA is present in chondrocytes at all ages.Chondroadherin is a cartilage matrix protein thought to mediate adhesion of isolated chondrocytes. The protein contains 11 leucine-rich repeats flanked by cysteine-rich regions. The chondroadherin messenger RNA is present in chondrocytes at all ages.
Alias Symbols: SLRR4A
Protein Interaction Partner: COL2A1
Protein Size: 359 -
Molecular Weight
- 38 kDa
-
Gene ID
- 1101
-
NCBI Accession
- NM_001267, NP_001258
-
UniProt
- O15335
Target
-